AB001. Development of tumour-targeted therapy for the treatment of adult and paediatric high-grade gliomas
The results obtained from this work serve as proof of principle that enables tumour-specific drug delivery to treat HGG. This work also paves the way for treating other brain cancers and central nervous system (CNS) disorders like Parkinson's and Alzheimer's disease, for which no adequate therapy exists.
Authors
- Carine Lee
- Elizabeth Cooper (ORCID: https://orcid.org/0000-0002-6519-4753)
- William A. Denny (ORCID: https://orcid.org/0000-0001-7997-1843)
- Kihwan Hwang (ORCID: https://orcid.org/0000-0001-7211-729X)
- Jiney Jose (ORCID: https://orcid.org/0000-0002-1325-438X)
- Chae‐Yong Kim (ORCID: https://orcid.org/0000-0001-9773-5553)
- Peter J. Choi (ORCID: https://orcid.org/0000-0001-7195-3683)
- Thomas Park (ORCID: https://orcid.org/0000-0002-7995-8865)
- Michael Dragunow
- Kyung Mi Nam
Institutions
- University of Auckland (NZ)
- Seoul National University Bundang Hospital (KR)
- Cancer Society of New Zealand (NZ)
Publication Details
- Journal
- Chinese Clinical Oncology
- Published
- 2024-08-01
- DOI
- https://doi.org/10.21037/cco-24-ab001
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00